首页> 外文期刊>Pharmacoepidemiology and drug safety >Acetaminophen overdose: a little recognized public health threat.
【24h】

Acetaminophen overdose: a little recognized public health threat.

机译:乙酰氨基酚过量:一点认可的公共卫生威胁。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Recent concerns regarding acetaminophen overdose have lead multiple stakeholders to collaborate towards advancing the safe use of over-the-counter (OTC) and prescription medications. Although the majority of acetaminophen overdose cases are intentional overdoses, recent reports indicate that unintentional acetaminophen overdose in the USA continues to exist.1 More importantly, unintentional overdose of acetaminophen is the overdose type most likely to result in hospitalization, liver injury, or death. The Federal Drug Administration's (FDA) Center for Drug Evaluation and Research recently held a public workshop to assess current research in the area and to foster further investigation. In addition, early this year, the FDA announced that it will be requesting modifications to current practice in two specific areas: (i) reduction of dosing per tablet or capsule of any product containing acetaminophen and (ii) requiring warnings for prescription medications containing acetaminophen.
机译:最近对醋氨酚过量的担忧促使多个利益相关者合作,以促进非处方药(OTC)和处方药的安全使用。尽管大多数醋氨酚过量病例都是故意过量,但最近的报告表明,美国仍然存在非故意的醋氨酚过量。1更重要的是,意外过量服用对乙酰氨基酚是最有可能导致住院、肝损伤或死亡的过量类型。美国联邦药物管理局(FDA)药物评估和研究中心最近举办了一次公共研讨会,以评估该领域的当前研究,并促进进一步调查。此外,今年年初,美国食品和药物管理局宣布,它将要求在两个具体领域修改现行做法:(i)减少任何含有对乙酰氨基酚的产品的每片或胶囊的剂量;(ii)要求对含有对乙酰氨基酚的处方药发出警告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号